Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Not Yet Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

NCT07728188

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: University of Arizona Cancer Center /ID# 285339 Tucson, Arizona, United States

Toi Clinical Research - Whittier /ID# 284462 Cerritos, California, United States

University of California Los Angeles /ID# 282444 Los Angeles, California, United States

University Of Colorado - Anschutz Medical Campus /ID# 283478 Aurora, Colorado, United States

View all 66 locations

View Trial Details

Not Yet Recruiting

Iberdomide (CC-220) Priming to Improve T Cell Fitness Prior to Leukapheresis for Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)

NCT07727668

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Not Yet Recruiting

A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma

NCT07726160

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, China

View Trial Details

Not Yet Recruiting

CD19-B Cell Depletion in PAIS-ME/CFS Patients

NCT07724834

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, COVID-19, +37 more
Locations: Charité - Universitätsmedizin Berlin Berlin, Germany

View Trial Details

Not Yet Recruiting

Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma

NCT07725406

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

View Trial Details

Not Yet Recruiting

Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System

NCT07721350

Conditions: Amyloidosis, Behavior, Blood Protein Disorders, +21 more
Locations: Hôpital Lyon-Sud Pierre-Bénite, France

View Trial Details

Not Yet Recruiting

Ultrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)

NCT07719647

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations: Hôpital Necker Enfants malades Paris, Île-de-France Region, France

View Trial Details

Not Yet Recruiting

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

NCT07720843

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

INfections in Patients Treated With CAR-T

NCT07713511

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bloodstream Infections, +29 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Not Yet Recruiting

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

NCT07714213

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, COVID-19, +32 more
Locations: Charité - Universitätsmedizin Berlin Berlin, State of Berlin, Germany

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions